JPS6011013B2 - 動物用薬剤 - Google Patents

動物用薬剤

Info

Publication number
JPS6011013B2
JPS6011013B2 JP47121265A JP12126572A JPS6011013B2 JP S6011013 B2 JPS6011013 B2 JP S6011013B2 JP 47121265 A JP47121265 A JP 47121265A JP 12126572 A JP12126572 A JP 12126572A JP S6011013 B2 JPS6011013 B2 JP S6011013B2
Authority
JP
Japan
Prior art keywords
virus
pharmaceutical
interferon
animals
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47121265A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4862912A (cs
Inventor
クリスチヤン シユトラウプ オツト−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS4862912A publication Critical patent/JPS4862912A/ja
Publication of JPS6011013B2 publication Critical patent/JPS6011013B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP47121265A 1971-12-10 1972-12-05 動物用薬剤 Expired JPS6011013B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2161344.5 1971-12-10
DE2161344A DE2161344C3 (de) 1971-12-10 1971-12-10 Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Publications (2)

Publication Number Publication Date
JPS4862912A JPS4862912A (cs) 1973-09-01
JPS6011013B2 true JPS6011013B2 (ja) 1985-03-22

Family

ID=5827622

Family Applications (2)

Application Number Title Priority Date Filing Date
JP47121264A Expired JPS5924137B2 (ja) 1971-12-10 1972-12-05 弱毒ウイルスの製造方法
JP47121265A Expired JPS6011013B2 (ja) 1971-12-10 1972-12-05 動物用薬剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP47121264A Expired JPS5924137B2 (ja) 1971-12-10 1972-12-05 弱毒ウイルスの製造方法

Country Status (22)

Country Link
JP (2) JPS5924137B2 (cs)
AR (1) AR204075A1 (cs)
AT (1) AT326817B (cs)
AU (1) AU473209B2 (cs)
BE (1) BE792484A (cs)
BG (1) BG21417A3 (cs)
CA (1) CA988848A (cs)
CH (1) CH577558A5 (cs)
CS (1) CS189587B2 (cs)
DD (1) DD108115A5 (cs)
DE (1) DE2161344C3 (cs)
DK (1) DK143201C (cs)
ES (1) ES409464A1 (cs)
FR (1) FR2162637B1 (cs)
GB (1) GB1356076A (cs)
HU (1) HU167086B (cs)
IE (1) IE36995B1 (cs)
NL (1) NL178014C (cs)
PH (1) PH12597A (cs)
SE (1) SE8400283D0 (cs)
SU (1) SU439956A3 (cs)
ZA (1) ZA728709B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers

Also Published As

Publication number Publication date
BE792484A (fr) 1973-06-08
ATA1041972A (de) 1975-03-15
CA988848A (en) 1976-05-11
DE2161344C3 (de) 1986-10-02
NL178014B (nl) 1985-08-01
DE2161344A1 (de) 1973-06-20
SE8400283L (sv) 1984-01-20
JPS4862912A (cs) 1973-09-01
CH577558A5 (cs) 1976-07-15
AU4992072A (en) 1974-06-13
JPS5924137B2 (ja) 1984-06-07
DE2161344B2 (de) 1980-05-08
AU473209B2 (en) 1976-06-17
ZA728709B (en) 1973-08-29
PH12597A (en) 1979-06-27
JPS4862919A (cs) 1973-09-01
DK143201C (da) 1981-12-14
AR204075A1 (es) 1975-11-20
NL178014C (nl) 1986-01-02
HU167086B (cs) 1975-08-28
SU439956A3 (ru) 1974-08-15
IE36995B1 (en) 1977-04-13
IE36995L (en) 1973-06-10
NL7216628A (cs) 1973-06-13
FR2162637A1 (cs) 1973-07-20
AT326817B (de) 1975-12-29
SE8400283D0 (sv) 1984-01-20
DD108115A5 (cs) 1974-09-05
DK143201B (da) 1981-07-20
FR2162637B1 (cs) 1976-07-02
ES409464A1 (es) 1976-03-16
GB1356076A (en) 1974-06-12
CS189587B2 (en) 1979-04-30
BG21417A3 (bg) 1976-05-20

Similar Documents

Publication Publication Date Title
JPH02243633A (ja) ワクチン製剤
KR100333113B1 (ko) 헬리코박터피롤리관련위십이지장질환의치료방법
US4110433A (en) Equine rhinopneumonitis virus
EP1420065A1 (en) Process for producing inactivated virus envelope
Glasgow et al. Isoprinosine: lack of antiviral activity in experimental model infections
US4049794A (en) Treatment of infections in animals
CN108969492B (zh) 一种猪瘟口服弱毒冻干疫苗及其制备方法
US4039656A (en) Production of attenuated viruses
Longley et al. Effect of isoprinosine against challenge with A (H3N2)/Hong Kong influenza virus in volunteers
Shipkowitz et al. Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees
US6726913B1 (en) Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
Woodward Rickettsial vaccines with emphasis on epidemic typhus-initial report of an old vaccine trial
JPS6011013B2 (ja) 動物用薬剤
US4017359A (en) Production of non-antigenic attenuated viruses
JP2004508424A (ja) 免疫調節調剤物
CN108703952B (zh) 一种猪瘟口服弱毒冻干疫苗用冻干保护剂及应用
Adu et al. Serum-virus simultaneous method of immunisation against peste des petits ruminants
RU2791454C1 (ru) Способ лечения вирусной диареи молодняка крупного рогатого скота
RU2678981C2 (ru) Композиция от бешенства, содержащая адъювант pika
RU2056861C1 (ru) Ассоциированная вакцина против сибирской язвы и ящура и способ профилактики сибирской язвы и ящура
RU2180238C1 (ru) Биологический препарат для профилактики и лечения желудочно-кишечных и респираторных болезней телят
RU2096454C1 (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирусвакцины против классической чумы свиней
Kieny et al. Development of animal recombinant DNA vaccine and its efficacy in foxes
Tan et al. Further studies on feline respiratory virus diseases: 1. Vaccination experiments
Stringfellow et al. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166)